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Abstract
Heart sounds, measured via cardiac micro-acceleration
(CMA), carry valuable information about the mechanical
and hemodynamic function of the heart. The aim of the
present study is to estimate systolic and diastolic time in-
tervals from CMA features, extracted by segmentation of
the first two heart sounds, i.e. onset, maximum energy
and end instants. CMA, ECG and echocardiographic au-
dio signals were acquired simultaneously on 60 patients
under different hemodynamic conditions. Linear models,
fitted between CMA features and echo timings, were eval-
uated with their correlation coefficient, model error and
coefficient stability. Models for mitral valve closing, aor-
tic valve closing and opening instants showed satisfactory
results, whereas the estimation of the opening instant of
the mitral valve was more difficult. This work suggests the
potential utility of CMA for monitoring cardiac function
and defining optimal, adaptive pacing configurations.
1. Introduction
Cardiac Resynchronization Therapy (CRT) is indicated
for patients suffering from drug-refractory congestive heart
failure (CHF) associated with inter-ventricular dyssyn-
chrony [1]. The implantation of a bi-ventricular stimulator
makes it possible to re-synchronize the electrical activation
of both ventricles. In order to maximize the cardiac me-
chanical function for a given patient, the atrio-ventricular
(AV) and inter-ventricular (VV) activation delays of the de-
vice have to be optimized.
This optimization process is a difficult task that often
involves an echo-Doppler acquisition, in order to evaluate
the ventricular mechanical function, while scanning differ-
ent values for AV and VV delays. This cumbersome tech-
nique is not applied systematically and is only done at rest,
in supine position. Instead, the possibility of using a car-
diac acoustic signal to monitor the mechanical function of
the heart would be interesting from several points of view:
i) it will ease the application of the optimization stage, re-
ducing costs, ii) it will allow the evaluation on different
conditions (rest, exercise, etc.), and iii) it could eventually
be embedded into a pacemaker in order to perform an au-
tomatic and adaptive CRT optimization.
The study of cardiac acoustic signals has shown to be
useful for the evaluation of the mechanical function of
the heart. Methods for the analysis of the phonocardio-
gram (PCG) or the seismocardiogram (SCG) have been
proposed to extract useful information and to perform
heart sounds segmentation [2–5]. The arrival of Doppler
echocardiography significantly reduced the clinical use of
these signals, but the precision and reproducibility of echo-
Doppler measurements have been repeatedly criticized [6].
This fact might lead to a renewed interest in quantitative
analysis of cardiac acoustic signals, especially in the field
of CRT [7].
In this context, previous studies have shown that the
measurement of heart sounds via endocardial acceleration
(EA) (see Fig 1), developed by Sorin Group CRM, may be
valuable for an online follow-up of the cardiac mechani-
cal function. In particular, the peak to peak amplitude of
first component of the EA signal (EA1) is well correlated
to the maximum rate of rise of left ventricular pressure [8]
and has been successfully used to optimize CRT [1].
The present study focuses on a non-invasive cardiac
micro-acceleration (CMA) device, based on an external
version of the EA sensor, placed on the chest of the pa-
tient. The potential use of CMA in the context of CRT is
evaluated by a quantitative comparison between extracted
CMA timings and Doppler-based time intervals. An eval-
uation methodology is proposed to assess the performance
of different heart sounds segmentation algorithms.
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2. Methods
2.1. Protocol
This study is based on a non-interventional multi-centre,
prospective registry, including 51 CHF patients, and 9
healthy subjects.
Each patient recording was collected during a routine
follow-up including echocardiographic measurements. 51
heart failure patients, with implanted CRT pacemakers
have been studied. In order to change the systolic and di-
astolic time intervals, different pacing configurations were
tested: i) biventricular pacing, ii) right ventricular (RV)
pacing, iii) left ventricular (LV) pacing, and, when possi-
ble, iv) spontaneous rhythm. For some patients, different
AV and VV delays were tested.
Echo stress tests were performed on 9 healthy volun-
teers at rest, during exercise (cycling), and during recov-
ery. These subjects are important, because focusing on
CRT patients only would lead to a limited exploration of
the possible values of the studied parameters. For exam-
ple, healthy subjects show shorter left pre-ejection interval
(LPEI) values and shorter cardiac cycles during controlled
exercise.
For each configuration, a simultaneous recording of
CMA, 2-Lead ECG and pulsed-wave Doppler audio sig-
nal, taken from the audio output of a GE Vivid7, were ac-
quired with a Biopac MP35 acquisition system at 10kHz.
The CMA sensor was clipped with a standard surface ECG
electrode on the sternum of the patient and analogically fil-
tered in the [15-100Hz] range. Data was processed off-line
with custom Matlab signal processing routines.
2.2. Gold standard Doppler measurements
ECG signals were used to segment CMA and Doppler
signals into cardiac cycles. We performed an automatic
beat detection from ECG signals, and then manually veri-
fied and corrected the results. This first step, yet simple, is
a real improvement regarding the method used in every day
clinical practice. We attached much importance to the ac-
curacy and reproducibility of the Doppler measurements.
Mitral and aortic blood flow were reconstructed from the
Doppler audio signal by applying short-time FFT, with a
Hamming window of 64 samples (Fig. 1). To ease the
annotations, a flow envelogram was estimated by first in-
tegrating the Doppler velocities at each time sample and
then applying a moving-average filter.
Four valvular events were annotated by a trained opera-
tor and validated by an expert echocardiographist: i) tMC
= tREF to mitral valve closing, ii) tAO (LPEI) = tREF
to aortic valve opening, iii) tAC = tREF to aortic valve
closing, iv) tMO = tREF to mitral valve opening, where
tREF is either the beginning of the pacing spike or the be-
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Figure 1. ECG, CMA and aortic flow Doppler. The be-
ginning of each beat, the opening and closing of the aortic
valve appear as dotted lines on the lower panel.
ginning of the Q wave in spontaneous rhythms. When the
echo measurements confidence on a segment was judged
too low by the echocardiographist, the segment of data was
rejected from the database.
2.3. Extraction of CMA timings
For each configuration, 15 cycles of CMA signal, oc-
curring during the acquisition of the pulsed wave Doppler,
are considered for standard ensemble averaging of the two
main components of the CMA signal, EA1 and EA2 (cor-
responding respectively to the first and second heart sound
in the PCG), separately: i) the phase shifts that maxi-
mize the correlation between each cycle are calculated, ii)
the cycles are aligned according to a reference component
(first cycle of the analysis window) and iii) the two aver-
age components EA1 and EA2 are computed. Only highly
correlated cycles are averaged.
Envelograms are computed on this average CMA cycle,
by applying both the Shannon and Homomorphic trans-
forms. These transforms have already been applied to the
segmentation of PCG signals [3, 4].
Finally, a threshold-based segmentation algorithm is ap-
plied to the envelograms. Again, EA1 and EA2 envel-
ograms are normalized and processed separately, in or-
der to estimate their start and end instants (tEAxStart and
tEAxEnd respectively) and their instant of maximum en-
ergy (tEAxmaxenergy ). Scanning different values of w (de-
fined as the duration of the moving-average window for
the Shannon transform and the low-pass filter cut-off fre-
quency for Homomorphic envelograms) and threshold
(from 0.1 to 0.7 by steps of 0.1) generates different CMA
instants.
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2.4. Performance assessment
We first removed outlier points (typically outside the
30ms model error boundaries). A linear model (tV. =
a · feat + b, where tV. is the reference event for valve
V and feat is a CMA feature) was then estimated by
standard RMSE minimization. Two complementary ap-
proaches were used to evaluate each model:
• Single-pass: a single model is estimated per feature on
N points (all patients and configurations included). This
model is globally evaluated with its correlation coefficient
rL, its average absolute error µerr, and the percentage of
points outside the 20ms error limit %out.
• Monte-Carlo: on the entire database (DB), we generate
27 different pairs of learning DB (60 % of the DB), on
which the model is estimated, and test DB (40 % of the
DB), on which the model is evaluated. In each case, rT
and the model error are calculated. We can then estimate
the average correlation coefficient µrT and the stability of
the models for each feature: the standard deviation of each
model’s coefficient (a and b) is calculated (σa and σb).
3. Results and discussion
The best CMA feature for each one of the 4 reference
echo timings are detailed in Table 1, with their correspond-
ing optimal segmentation parameters. It is worth to note
that these optimal parameters vary for different echo tim-
ings, even if the same CMA feature is selected. For tAO,
we specified 2 different CMA features because they pro-
vide similar performance.
• Valves Closing Times (tMC and tAC): tMC can
be estimated accurately from several tEA1Start features :
µerr = 12ms, rL = 0.89 and %out = 16. Similarly,
several tEA2Start timings are good estimators of tAC:
µerr = 9ms, rL = 0.98 and %out = 7. Figure 2 presents
an example of the estimation of tAC from tEA2Start by
using a Homomorphic envelogram with w = 15Hz and
threshold = 0.6.
Moreover, these models are very stable: σa values for
tMC models are relatively low (2.6 % variations of their
corresponding a value) and for tAC models (0.6 % varia-
tions). The same stability is observed on the b coefficients
for tMC and tAC models (σb = 3ms).
• Valves Opening Times (tMO and tAO): a satisfactory
estimation of the absolute value of tAO with the present
extracted CMA timings was difficult to obtain, in compar-
ison with those obtained for valve closing instants, but the
best model involving a tEA1Start feature presents over-
all interesting properties: µerr = 17ms, rL = 0.86 and
%out = 35. This can be explained by the fact that several
complex physiopathological phenomena (including tMC
and tAO) are at the origin of EA1 (as for the first heart
sound in the PCG) and their relative time of occurrence
may vary in an intra and inter-patients fashion. However, a
good correlation exists between tEA1Start (see Fig. 3) or
tEA1maxenergy and the Doppler LPEI, as shown in Table 1.
Concerning tMO, we are not currently able to locate this
particular time instant in the CMA signal. In this case,
the presence of healthy subjects at rest and performing ex-
ercise has a great influence on the correlation rL = 0.9,
despite a high model error µerr = 27ms and a signifi-
cant proportion of patients out of the 20ms error bound-
aries %out = 62.
The Monte Carlo analysis demonstrates that these models
are more unstable, especially on tMO. σa are high for
tAO models (8% variations of their respective a value for
tEA1Start and 11% for tEA1maxenergy ) and tMO models
(8 % variations). This is particularly true for the b coeffi-
cients on tAO (σb = 14ms for tEA1Start and 21ms for
tEA1maxenergy ) and tMO models (σb = 46ms).
It should be observed that tEA1Start features correlate well
to both tAO and tMC, despite the lack of a significant cor-
relation between these two Doppler instants (r = 0.59).
This may be due to the fact that i) tEA1Start detection
instants are more stable than those of tEA1maxenergy (re-
spectively σa = 0.094 and 0.118) and ii) the delay sepa-
rating tMC and tAO (the isovolumic contraction time) is
absorbed by the model’s coefficients (b = 37ms for tAO
and 5ms for tMC). This phenomenon is similar to the
one observed on tAC (small model error) and tMO (large
model error), except that here the two Doppler instants are
significantly correlated (r = 0.87).
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Figure 2. tAC model estimation from tEA2Start
3.1. Conclusion
Results clearly demonstrate the feasibility of estimat-
ing the mitral and aortic valve closing instants from car-
diac micro-acceleration features and suggest their poten-
tial application in a clinical context. Regarding tAO, we
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Table 1. Model performances
CMA feature Method w thres. N µerr σerr rL %out µrT σa σb
tMC tEA1Start Shannon 40ms 0.4 172 12 ms 8 ms 0.89 16 0.88 0.025 0.003
tAO tEA1Start Shannon 80ms 0.6 170 17 ms 13 ms 0.86 35 0.81 0.094 0.014
tAO tEA1maxenergy Shannon 150ms - 170 17 ms 14 ms 0.83 37 0.78 0.118 0.021
tAC tEA2Start Homomorphic 15Hz 0.6 172 9 ms 7 ms 0.98 7 0.96 0.006 0.003
tMO tEA2Start Shannon 80ms 0.2 182 27 ms 17 ms 0.9 62 0.83 0.098 0.046
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Figure 3. tAO model estimation from tEA1Start
obtained suitable models for two different types of EA1
features. Ongoing work is directed to the improvement of
the estimation of mitral valve opening instant. The pro-
posed algorithms showed to be robust with respect to envi-
ronmental noise and artifacts, usually present on this kind
of surface acoustic signals. It would now be relevant to
evaluate the stability of the CMA timings during a given
hemodynamic configuration, on successive groups of car-
diac cycles.
We chose echocardiographic measurements as a gold
standard, despite its drawbacks, (i.e. operator dependency,
position of the transducer, limited number of beats), be-
cause it is still recognized by the physician community as
a reference method. These limitations have to be kept in
mind, even though we significantly enhanced the reliabil-
ity of this reference with specific signal processing tools.
To conclude with, the clinical potential of these CMA
features seems really promising, and, combined with ap-
propriate implantable sensors and stimulators, could set
the grounds for a significant advance in CRT.
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